Table 7

Gemcitabine and difluorodeoxyuridine plasma Cmax, AUC and half life in patients (n=7) given gemcitabine 800 mg/m2with PR-104. (Mean ± standard deviation)
Cmax (mg/L) AUC (mg/L*hr) t1/2(hr)
Gemcitabine 20.8 ± 10.6 4.87 ± 1.69 0.21 ± 0.06
Difluorodeoxyuridine 30.8 ± 9.56 219 ± 57.6 12.2 ± 2.34

a Values and mean ± SEM.

McKeage et al.

McKeage et al. BMC Cancer 2012 12:496   doi:10.1186/1471-2407-12-496

Open Data